FDA UNTITLED_LETTER - Davis City Pharmacy Inc. - February 17, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Davis City Pharmacy Inc.

Record Details

This UNTITLED LETTER record concerns Davis City Pharmacy Inc., with an inspection on February 17, 2022, issued by the Office of Pharmaceutical Quality, covering drugs.

Company: Davis City Pharmacy Inc.
Inspection Date: February 17, 2022
Product Type: Drugs
Office: Office of Pharmaceutical Quality
People: Shawn E. Larson (Development Coordinator)
Brandi M. Chane-lee
Dayna Martinez (Senior Compliance Officer)

Open in Dashboard

ID · 7aac71cd-7ccf-49e1-9ea2-d38537ed41b1

Violation Codes10

FD&C Act 501(a)(2)(B)FD&C Act 502(f)(1)FD&C Act 505FD&C Act 501(a)(2)(A)FD&C Act 301(k)21 CFR 201.11521 CFR 210.1(b)21 CFR 200.10(b)21 U.S.C. 352(f)(1)21 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.